Regenesis Biomedical is a device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain, restore health, and improve quality of life. As a company we value dedication, innovation, integrity, respect, excellence, compassion and teamwork.
Regenesis currently offers the Provant Therapy System, which is safe, non-drug pain management.
Our customers include health care facilities and providers that serve patients treated in acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, and outpatient clinics, as well as by patients in their homes under physician orders.
Regenesis Biomedical, Inc. was founded in 1997 as a Delaware C corporation. The Company is privately held and current investors include venture capital firms, management and private investors.